LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,469,000 | -50.5% | 28,674 | -48.8% | 0.53% | +3.9% |
| Q2 2022 | $4,992,000 | +19.1% | 55,960 | +50.2% | 0.51% | -30.2% |
| Q1 2022 | $4,190,000 | -39.4% | 37,246 | -16.8% | 0.74% | -34.0% |
| Q4 2021 | $6,913,000 | +9.9% | 44,754 | -0.9% | 1.12% | -7.8% |
| Q3 2021 | $6,291,000 | +15.3% | 45,153 | +8.5% | 1.21% | +15.0% |
| Q2 2021 | $5,458,000 | -18.7% | 41,600 | -5.5% | 1.05% | -22.3% |
| Q1 2021 | $6,712,000 | +100.9% | 44,028 | +31.1% | 1.35% | +86.2% |
| Q4 2020 | $3,341,000 | +90.7% | 33,594 | +82.8% | 0.73% | +66.5% |
| Q3 2020 | $1,752,000 | – | 18,375 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |